These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 37062252)

  • 1. Are we there yet? cellular therapies for cutaneous T cell lymphoma.
    Atilla PA; Atilla E
    Curr Res Transl Med; 2023; 71(2):103390. PubMed ID: 37062252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic Treatment Options for Advanced-Stage Mycosis Fungoides and Sézary Syndrome.
    Photiou L; van der Weyden C; McCormack C; Miles Prince H
    Curr Oncol Rep; 2018 Mar; 20(4):32. PubMed ID: 29572582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic transplantation and cellular therapies in cutaneous T-cell lymphoma.
    Goyal A; Foss F
    Expert Rev Anticancer Ther; 2024; 24(1-2):41-58. PubMed ID: 38224371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sézary syndrome. Part II: Prognosis and management.
    Oh Y; Stoll JR; Moskowitz A; Pulitzer M; Horwitz S; Myskowski P; Noor SJ
    J Am Acad Dermatol; 2021 Nov; 85(5):1093-1106. PubMed ID: 33945836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spotlight on Mogamulizumab-Kpkc for Use in Adults with Relapsed or Refractory Mycosis Fungoides or Sézary Syndrome: Efficacy, Safety, and Patient Selection.
    Blackmon AL; Pinter-Brown L
    Drug Des Devel Ther; 2020; 14():3747-3754. PubMed ID: 32982179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How we treat advanced stage cutaneous T-cell lymphoma - mycosis fungoides and Sézary syndrome.
    Sethi TK; Montanari F; Foss F; Reddy N
    Br J Haematol; 2021 Nov; 195(3):352-364. PubMed ID: 33987825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Memorials and mandates for cutaneous lymphomas.
    Heald PW
    Arch Dermatol; 2003 Jul; 139(7):926-8. PubMed ID: 12873891
    [No Abstract]   [Full Text] [Related]  

  • 9. Overview of Cutaneous T-Cell Lymphomas.
    Larocca CA; LeBoeuf NR
    Hematol Oncol Clin North Am; 2019 Aug; 33(4):669-686. PubMed ID: 31229162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocosis fungoides--an update on a non-mycotic disease.
    Makdisi J; Friedman A
    J Drugs Dermatol; 2013 Jul; 12(7):825-31. PubMed ID: 23884501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial.
    Kim YH; Bagot M; Pinter-Brown L; Rook AH; Porcu P; Horwitz SM; Whittaker S; Tokura Y; Vermeer M; Zinzani PL; Sokol L; Morris S; Kim EJ; Ortiz-Romero PL; Eradat H; Scarisbrick J; Tsianakas A; Elmets C; Dalle S; Fisher DC; Halwani A; Poligone B; Greer J; Fierro MT; Khot A; Moskowitz AJ; Musiek A; Shustov A; Pro B; Geskin LJ; Dwyer K; Moriya J; Leoni M; Humphrey JS; Hudgens S; Grebennik DO; Tobinai K; Duvic M;
    Lancet Oncol; 2018 Sep; 19(9):1192-1204. PubMed ID: 30100375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy of cutaneous lymphoma--current practice and future developments.
    Dummer R; Kempf W; Hess Schmid M; Häffner A; Burg G
    Onkologie; 2003 Aug; 26(4):366-72. PubMed ID: 12972705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunobiology and treatment of cutaneous T-cell lymphoma.
    Goel RR; Rook AH
    Expert Rev Clin Immunol; 2024 Aug; 20(8):985-996. PubMed ID: 38450476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic hematopoietic stem cell transplantation in advanced stage mycosis fungoides and Sézary syndrome: a concise review.
    Johnson WT; Mukherji R; Kartan S; Nikbakht N; Porcu P; Alpdogan O
    Chin Clin Oncol; 2019 Feb; 8(1):12. PubMed ID: 30525754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local radiation for cutaneous T-cell lymphoma other than mycosis fungoides and Sézary syndrome.
    Shikama N
    Chin Clin Oncol; 2019 Feb; 8(1):8. PubMed ID: 30180750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of currently available therapies for the mycosis fungoides and Sezary syndrome variants of cutaneous T-cell lymphoma.
    Whittaker SJ; Foss FM
    Cancer Treat Rev; 2007 Apr; 33(2):146-60. PubMed ID: 17275192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bridging the specialty gap: Update on primary cutaneous lymphomas.
    Olsen EA; Hodak E; Geskin L; Scarisbrick J;
    J Am Acad Dermatol; 2024 Feb; 90(2):257-260. PubMed ID: 38043039
    [No Abstract]   [Full Text] [Related]  

  • 19. European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2017.
    Trautinger F; Eder J; Assaf C; Bagot M; Cozzio A; Dummer R; Gniadecki R; Klemke CD; Ortiz-Romero PL; Papadavid E; Pimpinelli N; Quaglino P; Ranki A; Scarisbrick J; Stadler R; Väkevä L; Vermeer MH; Whittaker S; Willemze R; Knobler R
    Eur J Cancer; 2017 May; 77():57-74. PubMed ID: 28365528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrating novel systemic therapies for the treatment of mycosis fungoides and Sézary syndrome.
    Prince HM; Querfeld C
    Best Pract Res Clin Haematol; 2018 Sep; 31(3):322-335. PubMed ID: 30213403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.